跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BETAFERON interferon beta-1b rbe 0.25mg (8 million IU) powder for injection vial with diluent syringe - TGA Drug Approval Details
Approvals
/
TGA
/
BETAFERON interferon beta-1b rbe 0.25mg (8 million IU) powder for injection vial with diluent syringe
Approved
STANDARD
BETAFERON interferon beta-1b rbe 0.25mg (8 million IU) powder for injection vial with diluent syringe
Bayer Australia Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
9f45a6ba042e44ef
Company
Bayer Australia Ltd
Type
Standard
Approval Details
Approval Id
9f45a6ba042e44ef
Product Name
BETAFERON interferon beta-1b rbe 0.25mg (8 million IU) powder for injection vial with diluent syringe
Artg Id
83309
Artg Name
BETAFERON interferon beta-1b rbe 0.25mg (8 million IU) powder for injection vial with diluent syringe
Sponsor
Bayer Australia Ltd
Company Detail Path
/organization/bayer-australia-ltd
Artg Date
2002-08-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/5a4aebaed704e1e1faf84927b31dfef1.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/a3ecb596bc9ceb9bf09cf14c4990c6c9.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
9f45a6ba042e44ef
Type
Standard
Back to TGA Approvals